Physician profile
Kevin Scully
NPI 1770978363
$9,122.66
in general payments reported to CMS, 2019-2025
3 companies · $8,984 in 2025
The $8,984 reported for 2025 was more than what 88% of Pediatric Endocrinology providers received nationally (typical 2025 total: $294).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $126 · 2022: $12.84 · 2025: $8,984.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $7,760 · Travel and Lodging: $1,021 · Food and Beverage: $203.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $7,760.00 |
| Travel and Lodging | $1,021.28 |
| Food and Beverage | $202.55 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Genzyme Corporation | $8,983.83 | 2025 | |
| Medtronic Minimed, INC. | $125.99 | 2020 | |
| E.R. Squibb & Sons, L.L.C. | $12.84 | 2022 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kevin Scully listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.